Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 459 | 1,797 | 1,491 | 3,191 | 3,853 |
| Gross Profit | 459 | 1,797 | 1,491 | 3,191 | 3,853 |
| Operating Expenses | 3,589 | 13,249 | 22,994 | 20,156 | 16,912 |
| Operating Income | -3,130 | -11,452 | -21,503 | -16,965 | -13,059 |
| Interest Expense | 4 | 378 | 328 | 69 | 694 |
| Other Income | -2,443 | 71 | 31 | 237 | 38 |
| Pre-tax Income | -5,577 | -11,759 | -21,801 | -16,797 | -13,715 |
| Net Income Continuous | -5,577 | -11,759 | -21,801 | -16,797 | -13,715 |
| Net Income Discontinuous | 13,591 | N/A | N/A | N/A | N/A |
| Net Income | $8,015 | $-11,759 | $-21,801 | $-16,797 | $-13,715 |
| EPS Basic Total Ops | 9.54 | -18.71 | -57.84 | -59.08 | -61.44 |
| EPS Basic Continuous Ops | -6.82 | -18.99 | -57.90 | -59.07 | -61.68 |
| EPS Basic Discontinuous Ops | 16.62 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 9.54 | -18.71 | -57.84 | -59.08 | -61.44 |
| EPS Diluted Continuous Ops | -6.82 | -18.99 | -57.90 | -59.07 | -61.68 |
| EPS Diluted Discontinuous Ops | 16.62 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -6.82 | -18.70 | -57.80 | -59.00 | -61.40 |
| EBITDA(a) | $-2,834 | $-11,112 | $-21,165 | $-16,585 | $-12,660 |